XHKG
0722
Market cap49mUSD
Dec 01, Last price
0.49HKD
1D
3.19%
1Q
0.00%
Jan 2017
-64.34%
IPO
-73.78%
Name
UMP Healthcare Holdings Ltd
Chart & Performance
P/E
9.41
P/S
0.51
EPS
0.05
Div Yield, %
6.80%
Shrs. gr., 5y
1.13%
Rev. gr., 5y
5.70%
Revenues
748m
+2.85%
Net income
41m
-32.77%
CFO
145m
-23.51%
Dividend
Dec 09, 20250.019 HKD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
UMP Healthcare Holdings Limited, an investment holding company, provides a range of medical and healthcare services in Hong Kong, Macau, and Mainland China. It operates in two segments, Corporate Healthcare Solution Services and Clinical Healthcare Services. The company offers virtual care; family medicine; specialist consultation services, including internal medicine, surgery, pediatrics, cardiology, dermatology, otorhinolaryngology, orthopedics, ophthalmology, urology, gastroenterology and hepatology, radiology, endocrinology, and diabetes; and dental care services, such as dental implant, cosmetic dentistry, periodontal treatments, and orthodontics, as well as traditional Chinese medicines. It also provides physiotherapy services comprises muscle-strengthening, limb function, eye-hand coordination, and hand function trainings; day surgery and endoscopy; diagnostic imaging and laboratory; health assessment; visa medical examination; vaccination and consultation; vision care and optometry; plastic, head, and neck surgeries; dermatology and aesthetics; chronic disease management; and COVID-19 screening test services. In addition, the company engages in the provision of healthcare training and consultation services. It serves insurance companies and corporations, and self-paid patients. The company operates a network of approximately 1,100 self-owned and affiliated service points. UMP Healthcare Holdings Limited was founded in 1990 and is headquartered in Central, Hong Kong.
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||